INLOG/HAEMONETICS at the ISBT LISBON on June 19th
06 / 15 / 2011
Inlog - a Haemonetics Company - will be present on the ISBT Congress on booth n° 415 - Hall 2. Congress Center : Praça das Indùstrias 1300-307 Lisboa. Please contact cnd@inlog.com for further more information.
Access to Haemonetics Events
06 / 15 / 2011
Inlog/HSS Events 2011/2012
4 mai SFTS, Lyon, France
03 mai SFIL, Vittel, France
18 juin SITS, Lisbonne, Portugal
7 septembre BBTS, Glasgow, Royaume-Uni
27 septembre DGTI, Hanovre, Allemagne
22 octobre AABB, San Diego, Etats-Unis
8 novembre JIB, Paris, France
9 novembre EATB, Barcelone, Espagne
About Haemonetics Corporation
08 / 29 / 2010
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at www.haemonetics.com.
Global Med Technologies®, Inc. Announces its First EdgeCell Cellular Therapy Software and EdgeLab/HLA Software Sale in North America
09 / 15 / 2009
Global Med’s Inlog, S.A. Subsidiary Demonstrates its Global Reach with Licenses to Héma Québec in CanadaDenver, CO Héma-Québec will use EdgeCell in its Stem Cell Laboratory and Public Cord Blood Bank. EdgeCell is a state-of-the-art Cellular Therapy software solution for hospitals, surgery centers and health care facilities. EdgeCell fully tracks the procurement process including the medical history questionnaire, all required testing including specimen reception and infectious disease testing, product preparation, packaging, labeling and storage, as well as crossmatching and distribution. EdgeCell incorporates an extensive list of safety features along with full traceability and generation of regulatory documentation. The complex nature of stem cell laboratories and cord blood banks dictates that distinct business rules and parameters be tailored to each type of product. EdgeCell meets these needs through its ability to configure and maintain distinct business rules and parameters for each type of product, be it stem cells or cord blood. Inlog has the ISO 9001:2000 and NSF/ISO 25051/12119 certification for EdgeCell, helping to assure a high level of quality in the design, testing and validation of the software, the documentation of the software and the quality of support and maintenance. Héma-Québec will utilize the Human Leukocyte Antigen (HLA) matching capability of EdgeLab for the complex process of HLA matching its patients for the Stem Cell Laboratory and the Public Cord Blood Bank. Since EdgeLab was introduced into the hospital market in 1999 as "Labo Serveur", it has become a leading laboratory information management system in Europe with more than 150 licensed laboratories. EdgeLab is connected to more than 1,000 analyzers and interchanges data with all major hospital healthcare software applications. EdgeLab can be easily configured to meet the business needs of large, diverse, multi-site hospital laboratories, as well as small, single-site hospitals. It has a vibrant, easy-to-use Windows graphical interface in addition to a comprehensive range of laboratory functionality. Dr. Francine Décary, President and Chief Executive Officer of Héma-Québec, stated that " t he management software package and the expertise by Global Med Technologies is a valuable solution that would enable Héma-Québec to optimize our stem cell laboratory operations and support the growth of the Public Cord Blood Bank." Michael I. Ruxin, M.D., Chairman and Chief Executive Officer of Global Med Technologies, Inc., stated, "We are very proud to have been selected by Héma-Québec as the software supplier for their state-of-the-art Stem Cell Laboratory and Public Cord Blood Bank. This sizable transaction is a major event for Global Med, expanding our distribution of EdgeCell and EdgeLab into Canada and North America." Dr. Ruxin added, "We expect that markets for both of these products could rise substantially in North America as demand grows for proven cellular therapy solutions. We feel we are well positioned to answer this demand with Global Med’s software solutions that are currently being implemented successfully in Europe and with top-notch support teams here in the United States." Thomas F. Marcinek, President and Chief Operating Officer of Global Med Technologies, commented, "The need for software solutions such as EdgeCell is rapidly increasing as more hospitals enter this emerging market. In fact, only a miniscule part of this market has been penetrated to date. With a global target market of more than 10,000 hospitals and surgical centers, we see EdgeCell as a growth platform that will greatly enhance our domestic and international expansion. We are confident in this product and its ability to provide the quality transplant management software our customers and potential customers have been seeking. As a forerunner in this essential technology, we are poised to satisfy the growing demand for proven biologic transplant management systems and to grow our global presence as a provider of quality healthcare software solutions." About the Héma-Québec Created in 1998, Héma-Quebec's mission is to efficiently provide adequate quantities of safe, optimal blood components, blood substitutes, human tissues and cord blood to meet the needs of all Quebec residents, as well as to provide and develop expertise, along with specialized and innovative services and products in the fields of transfusion medicine and human tissue transplantation. Héma-Québec has 1,300 employees, some 2,000 blood drives and more than 300,000 blood donors every year, 16,000 partner volunteers and more than 485,000 blood products delivered to hospitals in Quebec annually to fulfill the needs of patients. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med’s products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites. Global Med’s domestic companies are Wyndgate Technologies®, a leader in software products and services for donor centers and hospital transfusion services; eDono® , which offers web-based donor relationship management systems; and PeopleMed™, Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers. Global Med’s European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.
Pennsylvania Healthcare Provider Chooses Global Med Technologies®, Inc.’s Transfusion Solution
09 / 10 / 2009
Denver, CO – (September 10, 2009) – Global Med Technologies®, Inc. ("Global Med" or the "Company") (OTCBB:GLOB), an international e-Health, medical information technology company, today announced that its Wyndgate Technologies division has licensed and deployed its SafeTrace Tx® transfusion management software to Schuylkill Health of Pottsville, Pennsylvania. Schuylkill is also using the services of Global Med’s PeopleMed® subsidiary to validate the systems before go-live. Terms of the agreement were not disclosed.
SafeTrace Tx, first introduced in 1999, is an industry leader in transfusion management software. The system is designed to raise the standard of care for patients, improve safety, reduce waste and increase efficiency. SafeTrace Tx provides comprehensive tracking of orders, specimens, blood products, derivatives, and accessories with a complete testing and transfusion history in one consolidated record. These complex features will assist Schuylkill’s technologists in selecting appropriate blood products for their patients and will allow their hospitals to access patient data from any facility in their system.
Cheryl Gipe, MLT (ASCP), MT (HEW) Blood Bank Section Head for Schuylkill Medical Center-East explained, " Schuylkill wanted a common transfusion management system to monitor our blood banks and interface with our new CPSI laboratory information system. CPSI referred us to Wyndgate and one other vendor. In November 2008, after visiting a Wyndgate client to see the system live, we knew within 15 minutes that we wanted the Wyndgate SafeTrace Tx system. It is user friendly and has a great tracking system."
Ms. Gipe continued, "Our administration wanted the system in our hospital live by July 1, 2009. A typical implementation takes approximately nine months. With the help and support of Wyndgate, CPSI and PeopleMed, we were able to accomplish this in four months. Wyndgate’s team worked very hard to make sure we met the deadline. CPSI and Wyndgate made sure the interfaces worked properly and PeopleMed validated the system prior to go-live. I cannot say enough good things about the service we received."
PeopleMed’s validation services provided Schuylkill staff with AVI validation files in addition to their regular documentation after the go-live. The video files show PeopleMed staff performing the actual processes used during Schuylkill’s validation. These files will become invaluable training tools later when their staff needs to understand specific procedures.
Wm. Scott Dustin, Global Med’s Sr. Vice President of Sales and Marketing - the Americas, commented, " Schuylkill, Wyndgate and PeopleMed staffs worked together well to accomplish this impressive time line. We are very pleased that Schuylkill had the confidence in our products and our ability to deliver their system on time. We look forward to working with Schuylkill to complete implementations in their other facilities. We also appreciate our great relationship with CPSI." Mr. Dustin continued, "Global Med companies offer clients far more than quality information systems. As a business solutions company, we provide our clients with solutions and resources to help them achieve their objectives. Our team of professionals is dedicated to providing service at the highest level. We believe our business units continue to grow as a direct result of this commitment to the customer and delivering outstanding results."
About Schuylkill Health
Schuylkill Health, serving the coal region of Pennsylvania, is the result of an affiliation between two community hospitals formerly known as Good Samaritan Regional Medical Center and The Pottsville Hospital and Warne Clinic. On August 1, 2008, Schuylkill Health became the new parent organization for the hospitals and their affiliated entities. The organization includes two Medical Centers, a Rehabilitation Center, Home Health, School of Nursing, three Health Centers, an MRI Center, Dental Clinic, Outpatient Surgery Center, Women's Imaging Center, Sleep Disorders Center and Pathways Program.